After A 24% Drop, Is First Majestic Silver Nearing A Bottom?
forbes.com
Want to monitor RCUS?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor RCUSArcus Biosciences is an oncology-focused biopharmaceutical company leveraging its deep cross-disciplinary expertise to discover highly differentiated therapies and to develop a broad portfolio of novel combinations addressing significant unmet needs.